JAK2 and colorectal carcinoma: To further clarify the oncogenic effects of ENC1 on JAK2/STAT5/AKT axis activation in tumorigenesis and metastasis properties of CRC, CCK-8, and colony formation assays were first examined to assess the cell proliferation with or without ruxolitinib treatment.